Analysts think XFOR stock price could increase by 97%
Dec 12, 2025, 12:25 PM
-7.73%
What does XFOR do
X4 Pharmaceuticals, based in Boston, focuses on developing novel therapies for rare diseases, particularly those related to immune dysfunction. Its lead candidate, mavorixafor, targets chemokine receptor CXCR4, with additional pre-clinical candidates in development.
6 analysts think XFOR stock price will increase by 97.16%. The current median analyst target is $7.65 compared to a current stock price of $3.88. The lowest analysts target is $4.04 and the highest analyst target is $13.65.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.